An integrated genomic and metabolomic approach for defining survival time in adult oligodendrogliomas patients.
Bund C, Guergova-Kuras M, Cicek AE, Moussallieh FM, Dali-Youcef N, Piotto M, Schneider P, Heller R, Entz-Werle N, Lhermitte B, Chenard MP, Schott R, Proust F, Noël G, Namer IJ.
Bund C, et al. Among authors: lhermitte b.
Metabolomics. 2019 Apr 29;15(5):69. doi: 10.1007/s11306-019-1522-5.
Metabolomics. 2019.
PMID: 31037432